Introduction

Risk uncertainty governance in biotechnology refers to the legal and institutional process of making decisions when the risks of a scientific innovation are not fully known. Biotechnology may involve genetically modified organisms (GMOs), gene editing, stem-cell therapies, synthetic biology, and novel medicines. These innovations can offer significant benefits, but their effects may be difficult to predict because scientific evidence is incomplete, long-term outcomes are unknown, or the technology may behave differently under real-world conditions.

Risk uncertainty governance seeks to balance innovation with protection of human health, biodiversity, and the environment. It requires regulators to distinguish between measurable risk and scientific uncertainty, obtain independent expert advice, disclose limitations of available evidence, and revise decisions when new information emerges.

In India, this approach is supported by the Environment (Protection) Act, 1986, the 1989 Rules governing genetically engineered organisms, and constitutional principles under Articles 14 and 21. The precautionary principle is especially important: lack of complete scientific certainty should not automatically prevent reasonable safeguards against credible threats of serious or irreversible harm.

Important Case Laws

1. Vellore Citizens’ Welfare Forum v. Union of India, (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle as an essential part of sustainable development. It held that where there is a threat of serious or irreversible environmental damage, lack of complete scientific certainty should not delay preventive measures.

The Court explained that environmental authorities must anticipate and prevent degradation, and that the developer or industrial actor may bear the burden of demonstrating that its activity is environmentally benign. This principle is directly relevant to biotechnology innovations whose long-term effects remain uncertain.

Indian Kanoon+1

2. Gene Campaign v. Union of India, 2024 INSC 545

The Supreme Court examined regulatory approval of genetically modified mustard (DMH-11), including biosafety assessment and the precautionary principle. It held that decisions of GMO regulatory authorities are subject to judicial review and directed the Union Government to formulate a national policy on GM crops through consultation with relevant stakeholders.

The judges delivered separate opinions and differed on the validity of the approval. The judgment should therefore not be described as a unanimous endorsement or rejection of GM mustard. Its broader importance lies in demonstrating that biotechnology regulation must be scientifically informed, transparent, accountable, and open to judicial scrutiny when uncertainty exists.

Sci API+2

3. A.P. Pollution Control Board v. Prof. M.V. Nayudu, (1999) 2 SCC 718

The Supreme Court emphasised the importance of scientific expertise in environmental decision-making, particularly where uncertainty and complex technical questions are involved.

The case supports the use of expert committees, reliable scientific evidence, and precautionary assessment. In biotechnology governance, regulators should not treat incomplete data as conclusive proof of safety or danger; they should obtain expert input and determine whether further testing or safeguards are needed.

Principles of Risk-Uncertainty Governance

Effective governance of uncertain biotechnology risks should include:

Precaution: Take proportionate preventive measures against credible threats of serious harm.

Adaptive regulation: Revisit approvals as scientific evidence develops.

Independent expertise: Use qualified and independent scientific reviewers.

Transparency: Explain known risks, unknown effects, and evidentiary limitations.

Proportionality: Balance innovation and public benefit against the severity and likelihood of potential harm.

Monitoring: Require continuing surveillance, reporting, and corrective action where appropriate.

Conclusion

Risk uncertainty governance is essential for ensuring that biotechnology innovation proceeds responsibly. The precautionary principle does not demand a complete ban on uncertain technologies; it requires scientifically justified and proportionate safeguards. Vellore Citizens’ Welfare Forum provides the central Indian legal foundation, while Gene Campaign demonstrates the application of these principles to GM crop regulation. Together with A.P. Pollution Control Board v. Nayudu, these decisions support a governance model based on expert evaluation, transparency, monitoring, and regulatory flexibility.

Indian Kanoon+2